Logos Global Management LP Moon Lake Immunotherapeutics Transaction History
Logos Global Management LP
- $1.07 Billion
- Q2 2024
A detailed history of Logos Global Management LP transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Logos Global Management LP holds 750,000 shares of MLTX stock, worth $38.8 Million. This represents 3.09% of its overall portfolio holdings.
Number of Shares
750,000
Previous 750,000
-0.0%
Holding current value
$38.8 Million
Previous $33 Million
-0.0%
% of portfolio
3.09%
Previous 3.09%
Shares
2 transactions
Others Institutions Holding MLTX
# of Institutions
130Shares Held
58.2MCall Options Held
102KPut Options Held
75.9K-
Bvf Inc San Francisco, CA21.8MShares$1.12 Billion29.25% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$439 Million28.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$143 Million1.66% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.56MShares$132 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.27MShares$117 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.91B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...